← Evidence map

Observational studyMedicine2018

Gemcitabine plus S-1 for metastatic pancreatic cancer.

Hong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018
2019
2020
2021
2022
2023
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 30313120